A. Antonini et al., The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT, NEUROL SCI, 22(1), 2001, pp. 47-48
Neuroimaging studies of the striatal dopamine transporter (DAT) are useful
in the assessment of the dopaminergic system in Parkinson's disease (PD). W
e used positron emisson tomography (PET) and the tracer [11-C]FE-CIT to mea
sure DAT binding in the caudate nucleus and putamen of 31 patients with PD,
5 with essential tremor and 8 healthy control subjects. Of the patients wi
th PD, 17 were drug naive, while the others were either on levodopa or dopa
mine agonist monotherapy. DAT binding was significantly reduced in the caud
ate nucleus and to a greater extent in the putamen of PD patients compared
to both healthy controls and essential tremor individuals. No overlap was o
bserved between putamen values in PD and normals. No differences were found
between controls and essential tremor subjects. These data confirm that me
asurements of DAT binding can provide an accurate and highly sensitive meas
ure of degeneration in the dopamine system in PD.